CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,689,000 | +56.0% | 49,985 | +8.0% | 0.00% | +100.0% |
| Q1 2021 | $1,083,000 | -19.1% | 46,283 | -0.5% | 0.00% | -50.0% |
| Q4 2020 | $1,339,000 | +42.1% | 46,497 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $942,000 | -23.1% | 46,497 | +14.1% | 0.00% | 0.0% |
| Q2 2020 | $1,225,000 | +35.7% | 40,760 | +41.9% | 0.00% | 0.0% |
| Q1 2020 | $903,000 | -18.8% | 28,731 | +21.7% | 0.00% | 0.0% |
| Q4 2019 | $1,112,000 | +622.1% | 23,609 | -0.8% | 0.00% | – |
| Q3 2019 | $154,000 | -47.3% | 23,799 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $292,000 | -12.0% | 23,799 | -3.0% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | +1283.3% | 24,538 | +302.1% | 0.00% | – |
| Q4 2018 | $24,000 | -41.5% | 6,102 | 0.0% | 0.00% | – |
| Q3 2018 | $41,000 | – | 6,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |